DR. C. TUNA ACNE BLEMISH CONTROL SERUM- salicylic acid liquid 
Farmasi US LLC

----------

Dr. C. Tuna Acne Blemish Control Serum

Drug Facts

ACTIVE INGREDIENT

Salicylic Acid 1%

PURPOSE

Acne Treatment

USE

For the treatment of acne.

WARNINGS

For external use only

When using this product

skin irritation and dryness is more likely to occur if you combine this product with other topical acne skincare products. If irritation occurs, only use one topical acne skincare product at a time. Avoid sun exposure and use a sunscreen. Avoid contact with the eyes, lips and mouth. If contact occurs, flush thoroughly with water. Skin irritation may occur, characterized by redness or tingling; if increased, discontinue use and seek medical advice.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Do not use

if you have very sensitive skin or are sensitive to salicylic acid.

DIRECTIONS

Apply 2-3 drops once a day where needed on clean skin. Avoid the eye area. Follow with Acne Balancing Cream.

OTHER INFORMATION

Store at room temperature.

INACTIVE INGREDIENTS

Water/Aqua, Propylene Glycol, Glycerin, Sodium PCA, Glycolic Acid, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Xanthan Gum, Hamamelis Virginiana Water, Dehydroacetic Acid, Benzyl Alcohol, Sodium Benzoate, Potassium Sorbate, Triethanolamine, Salix Alba Bark Water, Tocopheryl Acetate.

Questions or Comments?

info@farmasius.com Monday – Friday (9 a.m – 6 p.m. EST) (786) 238-7338 

Package Labeling:

Updated inner labelupdated label pt1updated label pt2

DR. C. TUNA ACNE BLEMISH CONTROL SERUM 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:74690-011
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM PYRROLIDONE CARBOXYLATE (UNII: 469OTG57A2)  
GLYCOLIC ACID (UNII: 0WT12SX38S)  
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
XANTHAN GUM (UNII: TTV12P4NEE)  
DEHYDROACETIC ACID (UNII: 2KAG279R6R)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
TROLAMINE (UNII: 9O3K93S3TK)  
SALIX ALBA BARK VOLATILE OIL (UNII: PW3MX00JXN)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:74690-011-011 in 1 BOX01/20/2021
130 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00601/20/2021
Labeler - Farmasi US LLC (113303351)

Revised: 11/2023
Document Id: 09735173-2608-39fd-e063-6394a90aa6cf
Set id: b8dd63d7-4ff2-60bc-e053-2a95a90ad16c
Version: 4
Effective Time: 20231105
 
Farmasi US LLC